All articles tagged with #oncology
Amgen has acquired Dark Blue Therapeutics for up to $840 million, adding a novel investigational molecule targeting proteins MLLT1/3 to its oncology pipeline, aiming to improve treatment for acute myeloid leukemia (AML).
Amgen has acquired Dark Blue Therapeutics, a UK biotech specializing in targeted protein degraders for oncology, for up to $840 million, to enhance its pipeline for treating acute myeloid leukemia with a novel investigational molecule showing promising preclinical results.
Johnson & Johnson has completed its $3.05 billion acquisition of Halda Therapeutics, a biotech company with a novel RIPTAC platform for developing targeted oral therapies for solid tumors, including prostate cancer, aiming to revolutionize cancer treatment and expand its oncology portfolio.
Siddhartha Mukherjee advocates for treating metabolism as a primary target in cancer therapy, emphasizing tumor-informed dietary interventions combined with drugs to improve outcomes and prevent resistance, moving towards precision nutrition as a complement to pharmacology.
The FDA has appointed oncology expert Richard Pazdur as the new head of the Center for Drug Evaluation and Research, succeeding George Tidmarsh amid a period of leadership turmoil.
An oncologist explains that swollen lymph nodes are usually caused by infections or inflammation and are not necessarily a sign of cancer, addressing common concerns about cancer symptoms.
Cancer doctors highlight 12 key symptoms that should prompt a medical consultation, including unusual vaginal bleeding, changes in bowel habits, unexplained weight loss or gain, persistent pain, enlarged lymph nodes, skin changes on breasts, new lumps, breast tenderness, nipple discharge, cough or shortness of breath, fatigue, and persistent pain. Early detection through awareness and screening is crucial for better outcomes.
A study reveals that many cancer patients receive treatment aimed at extending life rather than comfort, often against their wishes, highlighting the need for better communication between doctors and patients about care goals.
Daiichi Sankyo and Merck's investigational drug ifinatamab deruxtecan has received FDA Breakthrough Therapy Designation for treating pretreated extensive-stage small cell lung cancer, based on promising clinical trial data, aiming to accelerate its development and approval.
A promising experimental treatment has shown remarkable results in causing cancer to vanish in patients, highlighting potential advancements in oncology therapies.
The article discusses various insights from oncologists about cancer causes, risk factors, and lifestyle choices, emphasizing that while some factors like smoking, alcohol, and poor diet increase risk, cancer can also occur due to genetics and bad luck. It highlights the importance of screenings, sun protection, and avoiding carcinogens, but also acknowledges that cancer can affect anyone regardless of lifestyle.
An oncologist shares 11 science-backed strategies to reduce cancer risk, emphasizing lifestyle choices such as skin care, nail health, diet, and alternative therapies like acupuncture, based on personal and scientific insights.
Oncology dietitian Nichole Andrews suggests healthier pizza toppings to reduce cancer risk by replacing processed meats like pepperoni with vegetables or chicken. Processed meats are classified as carcinogenic by the WHO, linked to colorectal cancer. Andrews recommends five pizza recipes: Veggie Delight with bell peppers and spinach, Mediterranean with olives and artichokes, Margherita with tomatoes and basil, White Pizza with kale and ricotta, and Pesto Chicken Veggie with zucchini and spinach, all emphasizing ingredients that may help prevent cancer.
Undiagnosed depression in cancer patients is a significant gap in treatment, with about a third of patients experiencing psychiatric disorders that often go unnoticed. This neglect can lead to higher mortality rates and increased suicide risk. While some cancer centers are integrating mental health services, access remains limited, especially for survivors. Patients are encouraged to advocate for their mental health needs, utilize self-screening tools, and participate in support groups. The integration of mental health care in oncology is slowly improving, but challenges persist due to systemic issues and resource shortages.
Oncologist Professor Justin Stebbing highlights the cancer risks associated with alcohol consumption, noting that even moderate drinking can increase the likelihood of developing various cancers, including breast, head and neck, and colorectal cancers. Scientific research shows that ethanol in alcohol breaks down into acetaldehyde, which can damage DNA and lead to cancer. Despite the social benefits of drinking, Stebbing emphasizes the importance of awareness and moderation, as alcohol is a controllable risk factor for cancer, particularly among younger adults.